You are here: Industry Insights > Layoff

News List

Selecta lays off staff as R&D cash crunch looms fiercebiotech
January 07, 2019
Selecta Biosciences is laying off more than one-third of its workforce. The cuts come as Selecta seeks to eke out its cash reserves and advance a gout drug that disappointed investors in phase 2......
“Downsizing Storm” of Multinational Pharmaceutical Enterprises Hits in 2018 Dishui Sinan
December 27, 2018
Is the “Cold Wave” of the Global Pharmaceutical Industry Coming?
GSK to hold on to its antibiotics business, but nearly 200 workers will go fiercepharma
October 08, 2018
It has been a tough rollercoaster ride for GlaxoSmithKline’s U.K. manufacturing site in Ulverston. Once slated to get a major biologics plant with hundreds of new jobs, GSK is now closing a part of the plant and laying off nearly 200 workers.
Bristol-Myers Squibb to lay off 149 as Wallingford, Connecticut, site nears closure fiercepharma
July 18, 2018
Following an earlier layoff round affecting 107 employees, Bristol-Myers Squibb is cutting an additional 149 staffers at its Wallingford, Connecticut, R&D site, with the aim to completely close it by the end of this year.
Stock Dives as Celldex Cuts 20% of Staff After Phase II Breast Cancer Failure biospace
April 26, 2018
On April 16, Celldex Therapeutics reported that its Phase IIb trial of glembatumumab vedotin (glemba) failed in a trial of metastatic triple-negative breast cancer
Teva to cut over 300 production jobs in Israel pharmafile
July 25, 2017
Teva, one of the world’s biggest generics firms and the biggest company in Israel, has revealed it plans to slash around between 300 and 350 jobs from its 7,000-strong workforce in its home country, 4,000 of which work in production
GSK to cut 320 jobs amid manufacturing revamp pharmatimes
July 21, 2017
GlaxoSmithKline is trimming its UK workforce by around 320 under a shake-up of its manufacturing network in the country, in a move designed to boost efficacy and competitiveness.